Zaraq Khan, M.B.B.S., a reproductive endocrinology and infertility expert at Mayo Clinic's campus in Minnesota, says there are a number of reasons reproductive organ transplantation is important and should be considered for future patient treatment plans. Ovarian tissue cryopreservation and transplantation is part of the field of oncofertility as well as other types of fertility preservation. when we do the transplant, we will do the cervix and the uterus, but not the fallopian tubes. The goal is to do something like in vitro fertilization on these women before the transplant. So we can know that they can develop eggs and we can make embryos and then develop those embryos to a stage where we can transfer them back to the uterus. While we do say that gestational carriers is one option for such women that may not be option for certain other women. And even following the principles of bioethics with complete patient autonomy, we can argue that there's a lot of things that are for and against uterine transplant. But if if the whole process is handled in a way where the patient is completely aware of the risks benefits and if there's expertise involved in the in the institution that's providing this service, we do that think and we hope that in the future this is going to become more and more common. We're hoping that in a decade or so this will become mainstream as we move in the future. If this is something that becomes mainstream and if all the issues are kind of dealt with and this is considered extremely safe. We may even think that relative uterine factor infertility ease things like recurrent misc marriages, things like intra uterine adhesions or Ascherman syndrome where you can't carry a pregnancy are severe congenital anomalies of the uterus with a lot of recurrent preterm labors, Those patients may also in the future be candidates for such technology, but as of right now where it's still in its infancy, I think we're going to limit this to patients with absolute uterine factor infertility.